Preferential expression of NY-BR-1 and GATA-3 in male breast cancer

BACKGROUND: Male breast cancer is an uncommon disease often discovered in advanced stage; thus, in the setting of metastatic adenocarcinoma, breast origin must be taken to account. Breast markers as NY-BR-1, GATA-3, mammaglobin, and BRST-2 are established tools for labelling primary and metastatic f...

Descripción completa

Detalles Bibliográficos
Autores principales: Biserni, Giovanni Battista, Di Oto, Enrico, Moskovszky, Linda Eszter, Foschini, Maria Pia, Varga, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794829/
https://www.ncbi.nlm.nih.gov/pubmed/29116378
http://dx.doi.org/10.1007/s00432-017-2542-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794829/
https://www.ncbi.nlm.nih.gov/pubmed/29116378
http://dx.doi.org/10.1007/s00432-017-2542-z

Ejemplares similares